Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple Myeloma
Clinical trial NCT00113204 · COMPLETED
Trial details
- NCT number
- NCT00113204
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2007-03-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.